Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ET7S | ISIN: CA47817E1034 | Ticker-Symbol: JNJ0
München
21.11.24
08:03 Uhr
13,800 Euro
0,000
0,00 %
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
JOHNSON & JOHNSON CDR Chart 1 Jahr
5-Tage-Chart
JOHNSON & JOHNSON CDR 5-Tage-Chart

Aktuelle News zur JOHNSON & JOHNSON CDR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:45King Luther Capital Management Corp Cuts Stock Position in Johnson & Johnson (NYSE:JNJ)4
MiJ&J Loses Around $24B in a Month: How to Play the Stock?4
MiJohnson & Johnson, Merck lay off workers in China as local headwinds take a toll5
MiJohnson & Johnson China begins layoffs amid global reduction of firm's workforce5
MiPureTech Health PLC - PRTC's Seaport Adds Microsoft and J&J Exec to BOD4
JOHNSON & JOHNSON CDR Aktie jetzt für 0€ handeln
MiJ&J, Merck Cut Jobs in China as Local Competition Takes Toll8
DiJ&J, Protagonist's oral psoriasis prospect scores in phase 3 pair, readying case against BMS' Sotyktu24
DiJ&J pill clears skin in two late-stage psoriasis studies6
DiJ&J plots filings after psoriasis drug clears phase 3 test6
DiJ&J China Starts Layoffs Amid New Round of Organizational Restructuring5
MoJ&J's skin disease drug meets main goals of late-stage study3
MoCHMP Recommends Approval Of Janssen-Cilag's Lazcluze + Rybrevant In EU For EGFR-mutated Advanced NSCLC283NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson company (JNJ), Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)...
► Artikel lesen
MoCHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC2
SaMeridian Investment Counsel Inc. Raises Holdings in Johnson & Johnson (NYSE:JNJ)7
FrJohnson & Johnson (NYSE:JNJ) Trading Up 0.7% - Here's What Happened4
FrCHMP Recommends Janssen-Cilag's Rybrevant + Lazcluze For EGFR-mutated Advanced Non-small Cell Lung Cancer771NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson company, Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
► Artikel lesen
FrThis Is What Whales Are Betting On Johnson & Johnson8
FrFDA Approves Johnson & Johnson's Varipulse Device for AFib3
FrEU regulators endorse meds from BMS, J&J, Eisai and more-plus a clutch of biosims25
FrBiotechs behind J&J-bought Yellow Jersey partner on another immunology asset4
Seite:  Weiter >>
866 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1